Mahdi Dolatyari

Mahdi Dolatyari

Auto-generated profile, based on publicly available information

Mahdi Dolatyari

Department of Pharmacology, University of Arizona

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
HSHarrison J. Stratton
Harrison J. Stratton
MDMahdi Dolatyari
Mahdi Dolatyari
CKCarol Kopruszinski
Carol Kopruszinski
AGAndre Ghetti
Andre Ghetti
SMStephanie Maciuba
Stephanie Maciuba
FPFrank Porreca
Frank Porreca
Scheduled surgeries elicit stress in many patients. Levels of preoperative stress, anxiety, and female gender are known risk factors for increased and prolonged postoperative pain. The mechanisms by which psychological stress increases postoperative pain, especially in women, remain unknown. We hypothesized that stress amplifies postoperative pain by sensitizing dorsal root ganglion (DRG) nociceptors. Prolactin (PRL) is a female-predominant neurohormone that is controlled by estrogen and stress. PRL signals at the prolactin receptor long (PRLR-L) and short (PRLR-S) isoforms to induce gene transcription and nociception, respectively. Critically, prolactin sensitizes female, but not male, murine, Macaque and human nociceptors, revealing an evolutionarily conserved mechanism with high translational potential for human therapy. Prior restraint stress (RS) increased the magnitude and duration of incisional injury–induced postoperative pain hypersensitivity in both male and female mice. In females, RS or incisional injury downregulated PRLR-L and increased PRL-dependent nociceptor excitability. Female selective inhibition of postoperative pain hypersensitivity was produced by a) pharmacological inhibition of pituitary PRL b) overexpression of DRG PRLR-L to bias PRL signaling away from PRLR-S and c) CRISPR/Cas9 editing of PRLR isoforms. PL200,019, our recently discovered monoclonal antibody against human PRL (hPRL), prevented hPRL-induced sensitization of human female nociceptors. Using female mice genetically modified to express hPRL, rather than murine PRL, PL200,019 prevented both stress and incisional injury–induced hypersensitivity. Preemptive inhibition of stress-induced nociceptor sensitization with a monoclonal antibody to sequester PRL can improve female postoperative pain, diminish the need for postoperative opioids and decrease the risks of transition to chronic pain.

15 June 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
HSHarrison J Stratton
Harrison J Stratton
MDMahdi Dolatyari
Mahdi Dolatyari
NDNicolas Dumaire
Nicolas Dumaire
AMAubin Moutal
Aubin Moutal
AGAndre Ghetti
Andre Ghetti
FPFrank Porreca
Frank Porreca
The recent demonstration of differences in transcript expression in human post-mortem sensory neurons suggests the possibility of sexually dimorphic pain mechanisms. To date, however, the concept of “male” and “female” nociceptors has not been demonstrated at a functional level. We now report sensitization of female, but not male, human nociceptors by prolactin revealing a female-selective mechanism that can be exploited to improve the treatment of pain in women.

15 November 2022 in Journal of Veterinary Behavior
Verified
Journal Article
Closed access
EKEmad Khalilzadeh
Emad Khalilzadeh
SMSeyyedata Mousavi
Seyyedata Mousavi
RBReza Bahadori
Reza Bahadori
MDMahdi Dolatyarieslami
Mahdi Dolatyarieslami